Shell Q3 chemicals sales volume jumps 13% to 5.33m tonnes

28 October 2010 07:54  [Source: ICIS news]

SINGAPORE (ICIS)--Shell reported on Thursday that volume sales at its chemicals segment grew 13% year on year to 5.33m tonnes, helped by the start-up of its petrochemicals complex in Singapore.

“Chemicals CCS (current cost of supplies) earnings compared to the third quarter 2009 reflected improved realised chemicals margins, higher chemicals sales volumes and lower operating costs,” the company said without providing the figures.

Shell said that during the three months to September, its chemicals manufacturing plant availability increased to 96% from 95% in the same period last year.

Meanwhile, the company’s overall downstream operations recorded a 75% year-on-year decline in CCS earnings to $325m (€237m). After cost adjustments, earnings stood at $264m, down 83% from the same period last year, Shell said.

For the nine-month period to September, downstream CCS earnings were up 26% to $2.54bn.

Shell reported a net profit of $3.46bn in the third quarter, up 7% from the same period last year, with the nine-month figure jumping 26% to $13.3bn.

As part of the company’s strategy of driving down costs and improving capital efficiency, Shell would continue with rationalising some operations.

“We expect some $7bn-8bn of asset sales in the 2010-11 timeframe, including exits from non-core refining and marketing positions in Europe and Africa, and rationalisation of our tight gas portfolio in North America, following recent acquisitions there,” said Shell president Peter Voser.

($1 = €0.73)

To discuss issues facing the chemical industry go to ICIS connect


By: Pearl Bantillo
+65 6780 4359



AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly